Gossamer Bio, Inc. (GOSS)

0.446 +0.01 (+1.97%) USD  |  NASDAQ  |  Apr 17, 16:00
0.44 -0.01 (-1.35%) Pre-Market: 08:18
More

Gossamer Bio SG&A Expense (Quarterly) : 10.90M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. 62.98M
Artelo Biosciences, Inc. 1.893M
Arvinas, Inc. 23.00M
Quince Therapeutics, Inc. 3.635M
Vir Biotechnology, Inc. 23.62M